C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture

More topics under "C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture" (249,111)
C12P 1 - Preparation of compounds or compositions, not provided for in groups , by using micro-organisms or enzymes; General processes for the preparation of compounds or compositions by using micro-organisms or enzymes (9,909)
C12P 11 - Preparation of sulfur-containing organic compounds (721)
C12P 13 - Preparation of nitrogen-containing organic compounds (13,813)
C12P 15 - Preparation of compounds containing at least three condensed carbocyclic rings (433)
C12P 17 - Preparation of heterocyclic carbon compounds with only o, n, s, se, or te as ring hetero atoms (13,366)
C12P 19 - Preparation of compounds containing saccharide radicals (43,092)
C12P 21 - Preparation of peptides or proteins (112,499)
C12P 23 - Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (1,631)
C12P 25 - Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin (321)
C12P 27 - Preparation of compounds containing a gibbane ring system, e.g. gibberellin (37)
C12P 29 - Preparation of compounds containing a naphthacene ring system, e.g. tetracycline (146)
C12P 3 - Preparation of elements or inorganic compounds except carbon dioxide (1,939)
C12P 31 - Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins (92)
C12P 33 - Preparation of steroids (1,659)
C12P 35 - Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin (1,082)
C12P 37 - Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin (637)
C12P 39 - Processes involving micro-organisms of different genera in the same process, simultaneously (955)
C12P 41 - Processes using enzymes or micro-organisms to separate optical isomers from a racemic mixture (4,784)
C12P 5 - Preparation of hydrocarbons (4,200)
C12P 7 - Preparation of oxygen-containing organic compounds (36,824)
C12P 9 - Preparation of organic compounds containing a metal or atom other than h, n, c, o, s, or halogen (971)

Patents for C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture (838)
03/2001
03/27/2001	US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration
03/27/2001	US6207417 DNA encoding stem cell factor
02/2001
02/27/2001	US6194181 Producing epothiolones in a culture medium by providing microorganisms such as myxobacteria which produce epothiolones, and adding a complex-forming agent soluble in the culture medium, such as cyclodextrins; antitumor agents
02/22/2001	WO2001012822A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/22/2001	WO2001012821A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/22/2001	WO1999053086A8 Small molecule anticancer compounds and related production process
02/22/2001	CA2381427A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/14/2001	EP1075533A1 Small molecule anticancer compounds and related production process
01/2001
01/31/2001	CN1282422A Determination of cellular growth abnormality
01/04/2001	WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001	WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001	WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001	WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
01/04/2001	WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001	CA2383875A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
01/04/2001	CA2383865A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/04/2001	CA2380871A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
01/04/2001	CA2380870A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
01/04/2001	CA2380863A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/2000
11/29/2000	EP1054994A2 Fermentative preparation process for cytostatics and crystal forms thereof
11/29/2000	EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
09/2000
09/27/2000	CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/21/2000	WO2000039324A3 Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives
08/2000
08/30/2000	EP1031628A1 Process for the production of protease inhibitors
08/24/2000	WO2000049153A1 Fucosyl transferase gene
08/10/2000	WO2000046390A1 T helper cell epitopes
08/10/2000	WO2000046389A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000	WO2000046175A1 Microbial process for preparing pravastatin
08/10/2000	CA2361658A1 T helper cell epitopes
08/10/2000	CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/09/2000	EP1025444A1 Determination of cellular growth abnormality
08/08/2000	CA2149764C Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
08/02/2000	CN1261626A Method for producing L-amino acid
07/2000
07/06/2000	WO2000039324A2 Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives
07/05/2000	EP1016710A2 Method for producing L-amino acids
06/2000
06/30/2000	CA2291895A1 Method for producing l-amino acid
06/28/2000	CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/13/2000	US6074855 Fermenting a culture of a fungus selected from sporotrichum or phanerochaete species and isolating antibiotic compound; bactericides against helicobacter; antiulcer agents
06/07/2000	EP1005562A1 Succinic acid production and purification
06/07/2000	CN1255496A Application of heterobicyclic alcohol antimer for preparing piperazine derivative
06/06/2000	US6071713 Bioprocesses for preparing 7-ACA and 7-ADAC
05/2000
05/16/2000	CA2009675C Novel enzymatic cellulose derivative hydrolysate and fractions thereof
05/02/2000	CA2017636C Derivative of tissue-type plasminogen activator
04/2000
04/12/2000	EP0992579A1 Stem cell factor
03/2000
03/16/2000	WO2000014052A1 Microbial process for the preparation of acetic acid as well as solvent for its extraction from the fermentation broth
02/2000
02/22/2000	CA1340906C Fibronectin binding protein as well as its preparation
01/2000
01/25/2000	US6017726 Efficient process for producing 7-aminodeacetyl-cephalosoporanic acid by culturing penicillium chrysogenum with adipic acid, salt or ester to produce adipoyl-6-aminopenicillanic acid, then enzymatically altering molecule
12/1999
12/28/1999	CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999	CA1340861C Cysteine-depleted muteins of biologically active proteins
12/14/1999	CA1340847C Adhesin antigens
11/1999
11/25/1999	WO1999042602A3 Fermentative preparation process for cytostatics and crystal forms thereof
10/1999
10/21/1999	WO1999053086A1 Small molecule anticancer compounds and related production process
09/1999
09/28/1999	US5958744 Succinic acid production and purification
09/15/1999	EP0817863B1 Process for preparing spirolaxine and spirolaxine methyl ether
09/14/1999	US5952334 Carbocyclic compounds
09/01/1999	EP0939135A1 Substantially pure hetero-bicyclic alcohol enantiomers
08/1999
08/26/1999	WO1999042602A2 Fermentative preparation process for cytostatics and crystal forms thereof
08/26/1999	WO1999042601A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
08/26/1999	CA2321052A1 Process for the obtaining of hmg-coa reductase inhibitors of high purity
08/26/1999	CA2318818A1 Fermentative preparation process for cytostatics and crystal forms thereof
07/1999
07/20/1999	US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/14/1999	CN1222917A Novel protein and process for producing the same
06/1999
06/22/1999	US5914263 Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
05/1999
05/12/1999	EP0481000B1 Receptors for fibroblast growth factors
04/1999
04/29/1999	WO1999021014A1 Determination of cellular growth abnormality
04/28/1999	EP0911342A1 Novel protein and process for producing the same
04/27/1999	CA1340512C Expression of factor vii and ix activities in mammalian cells
04/07/1999	EP0906445A1 Enzymatic esterification process
03/1999
03/23/1999	CA2046595C Method for the production of xylitol from mixtures containing xylose
02/1999
02/25/1999	WO1999009196A1 Succinic acid production and purification
02/10/1999	EP0763133A4 Method for detecting a target nucleic acid
02/09/1999	US5869314 Tissue plasminogen activators and derivatives thereof as produced by recombinant means
02/09/1999	CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk
12/1998
12/29/1998	US5854280 Antifungal sordaridin derivatives
12/09/1998	EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
10/1998
10/22/1998	WO1998046644A1 Novel protein and process for producing the same
10/22/1998	CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/1998
09/09/1998	EP0863154A1 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods
09/08/1998	US5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria
09/01/1998	US5801047 Method for making stable extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
08/1998
08/18/1998	US5795745 Human growth hormone
08/11/1998	US5792649 In vitro culture medium containing microorganism expressing tyrosinase having activity stabilized by a reduced concentration of dissolved oxygen in the medium
08/11/1998	US5792644 DNA encoding an Eimeria 200 kd antigen
08/05/1998	EP0856516A1 Novel bioprocess for preparing 7-aca and 7-adac
08/04/1998	US5789233 Amino acid sequence that selectively binds with antibody; for preparation of a vector vaccine against coccidiosis.
07/1998
07/22/1998	CN1188509A Proteinase K resistant surface protein of neisseria meningitidis
07/22/1998	CN1188115A Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
07/14/1998	US5780289 Coccidiosis poultry vaccine DNA encoding an elmeria 20K antigen
06/1998
06/16/1998	US5766895 Dehydration of alcohol in adsorption, desorption using ion exchange resin
05/1998
05/19/1998	US5753486 Human tissue plasminogen activator
05/06/1998	CN1181108A Psychrophilic protease and psychrophilic bacteria
04/1998
04/29/1998	EP0838522A2 Coccidiosis poultry vaccine
03/1998
03/17/1998	US5728566 Tissue plasminogen activator derivatives
03/17/1998	US5728565 Methods of preparing tissue plasminogen activator derivatives
03/10/1998	US5726043 Process for the production of protease inhibitors
02/1998
02/11/1998	EP0500734B1 Protein complexes having factor viii:c activity and production thereof
01/1998
01/14/1998	EP0817863A1 Process for preparing spirolaxine and spirolaxine methyl ether
01/13/1998	US5707632 Immunology
12/1997
12/30/1997	US5702938 Human tissue plasminogen activator
12/24/1997	WO1997048817A1 Enzymatic esterification process

1 2 3 4 5 6 7 8 9